News

bHLH-PAS protein family includes proteins involved in cancer, metabolism, and immunity.

Novartis LEE011 (ribociclib) granted FDA Priority Review for first-line treatment of HR+/HER2- advanced breast cancer.

Suprise discovery has identified a possible trigger of chronic inflammation in diabetes.

Expands sample storage services in the U.S. and bioprocessing capabilities in China.

Collaboration aims to manufacture Redx’s breakthrough cancer treatment drug.

Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.

Adaptimmune announces collaboration with MSD to evaluate KEYTRUDA® (pembrolizumab) in combination with NY-ESO SPEAR® T-Cell therapy in multiple myeloma.

Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.

Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.

Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.